Has Kimberly Simmons received payments from drug or device companies?

Yes. Drug and device makers reported $322,986 in general payments to Kimberly Simmons across 135 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kimberly Simmons did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kimberly Simmons come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kimberly Simmons

Pediatric Endocrinology · Aurora, CONPI 1821315177

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (41.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Sanofi-aventis U.S. LLC accounts for 79.6% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $138,018, more than ten times the $681 reported in 2019. Among pediatric endocrinology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$322,986in general payments, 2019–2025

Across 135 payments — averaging $2392.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi-aventis U.S. LLC$257K
Sanofi$28K
Sanofi US Services Inc.$26K
Dexcom, Inc.$10K
Tandem Diabetes Care, Inc.$697
Medtronic$450
plus $444 from 2 others

$106,022in research payments, 2019–2025

Across 22 payments — averaging $4819.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sanofi US Services Inc.$36K
Novartis$35K
Sanofi-aventis U.S. LLC$35K

What the payments were for

Consulting fees$103,91432%
Speaking & faculty fees$134,75842%
Grants$570%
Travel & lodging$79,30925%
Food & beverage$4,8031%
Education$850%
Gifts$590%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi-aventis U.S. LLC	76	$257,036
Sanofi	7	$27,646
Sanofi US Services Inc.	8	$26,497
Dexcom, Inc.	34	$10,215
Tandem Diabetes Care, Inc.	4	$697
Medtronic	2	$450
Abbott	1	$300
Mannkind Corporation	3	$144

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$322,986 in reported general payments places this provider in the 95th percentile of 34 pediatric endocrinology providers in Colorado.

See all pediatric endocrinology providers in Colorado →

Other pediatric endocrinology in Aurora

Gregory ForlenzaAurora$200K
Marian RewersAurora$178K
Raj WadwaAurora$61K
Philip ZeitlerAurora$58K
Andrea SteckAurora$33K
Erin CobryAurora$15K
Georgeanna KlingensmithAurora$14K
Melanie CreeAurora$13K
Natalie NokoffAurora$13K
Robert SloverAurora$6K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →